Sort
82,697 grants matching “vaccine development”
Novel SIVsmm strains for analysis of mucosal transmission and vaccine protection
$2,256,286George M Shaw · University Of Alabama At Birmingham · P01 · FY2010 · AI
RNA-based HIV-1 chimera vaccines encoding a trimerizing host self-protein protomer linked to a viral MPER-TM segment
$2,256,224Ellis L Reinherz · Dana-Farber Cancer Inst · P01 · FY2025 · AI
Establish a Public Private Partnership for COVID19 Research
$2,255,883David N. Wholley · Foundation For The Nih · OT2 · FY2020 · OD
Vaccine Induced Immunity in the Young and Aged
$2,254,938Rafi Ahmed · Emory University · U19 · FY2021 · AI
B Cell Epitope Mapping of Zika
$2,254,716Daved Fremont · Washington University · N01 · FY2018 · AI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG) - Momi-Vax DMID #21-0004 {Supplement #6}
$2,253,969David S Stephens · Emory University · UM1 · FY2021 · AI
COBRE: Center for Computational Biology of Human Disease
$2,253,073David M Rand · Brown University · P20 · FY2023 · GM
Validation of the Remote Cognitive Aging and Alzheimerâs Disease REsearch (R-CARE) Toolbox for Diverse Populations
$2,253,049Richard B. Lipton · Albert Einstein College Of Medicine · R01 · FY2024 · AG
BRAIN TUMOR SPORE GRANT
$2,252,870Mitchel S. Berger · University Of California, San Francisco · P50 · FY2010 · CA
BRAIN TUMOR SPORE GRANT
$2,252,869Mitchel S. Berger · University Of California, San Francisco · P50 · FY2007 · CA
BRAIN TUMOR SPORE GRANT
$2,252,868Mitchel S. Berger · University Of California, San Francisco · P50 · FY2009 · CA
Alabama-Clinical Trials Unit
$2,252,736Michael S. Saag · University Of Alabama At Birmingham · UM1 · FY2013 · AI
Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases
$2,252,657Patrizia Farci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Phylodynamics of Cell Populations
$2,252,479Kenneth Hoehn · Dartmouth College · R35 · FY2025 · GM
SPORE in Skin Cancer
$2,252,176Meenhard Herlyn · Wistar Institute · P50 · FY2006 · CA
SPORE in Cervical Cancer
$2,251,770T.-C. Wu · Johns Hopkins University · P50 · FY2018 · CA
Prevention of AIDS
$2,251,746Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Conserved Element DNA Vaccine
$2,251,746Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Innovative Strategies to Combat Antibiotic-resistant Infections
$2,251,185Scott J Hultgren · Washington University · U19 · FY2025 · AI
Dana Farber/Harvard Cancer Center SPORE in Lung Cancer
$2,250,699David A Barbie · Dana-Farber Cancer Inst · P50 · FY2025 · CA
DEVELOPMENT OF ANTHRAX VACCINE FORMULATIONS
$2,250,652John Troyer · Pharmathene, Inc. · N01 · FY2015 · AI
The humoral response to Zika virus infection and vaccination
$2,250,553Theodore Pierson · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Center for Statistics and Quantitative Infectious Diseases
$2,250,371M Elizabeth Halloran · Fred Hutchinson Cancer Research Center · U54 · FY2015 · GM
Dana Farber/Harvard Cancer Center SPORE in Lung Cancer
$2,250,220David A Barbie · Dana-Farber Cancer Inst · P50 · FY2024 · CA
Innate and Adaptive Immune Responses in SARS-CoV-2 infection (COVID-19)
$2,250,196Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI